These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 7229908)

  • 1. Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data.
    Sheiner LB; Beal SL
    J Pharmacokinet Biopharm; 1980 Dec; 8(6):553-71. PubMed ID: 7229908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: routine clinical pharmacokinetic data.
    Sheiner LB; Beal SL
    J Pharmacokinet Biopharm; 1983 Jun; 11(3):303-19. PubMed ID: 6644555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic data.
    Sheiner LB; Beal SL
    J Pharmacokinet Biopharm; 1981 Oct; 9(5):635-51. PubMed ID: 7334463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods.
    Sheiner LB
    Drug Metab Rev; 1984; 15(1-2):153-71. PubMed ID: 6745080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model.
    Steimer JL; Mallet A; Golmard JL; Boisvieux JF
    Drug Metab Rev; 1984; 15(1-2):265-92. PubMed ID: 6745083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with NONMEM: analysis of routine phenytoin clinical pharmacokinetic data.
    Sheiner LB; Grasela TH
    Drug Metab Rev; 1984; 15(1-2):293-303. PubMed ID: 6547663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of population pharmacokinetic parameters of phenytoin using the parallel Michaelis-Menten and first-order elimination model.
    Valodia PN; Seymour MA; McFadyen ML; Miller R; Folb PI
    Ther Drug Monit; 2000 Jun; 22(3):313-9. PubMed ID: 10850399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic analysis of drug concentration data obtained during repetitive drug administration.
    Colburn WA; Gibaldi M
    J Pharm Sci; 1977 Apr; 66(4):530-3. PubMed ID: 856973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of phenytoin in Japanese patients with epilepsy: analysis with a dose-dependent clearance model.
    Odani A; Hashimoto Y; Takayanagi K; Otsuki Y; Koue T; Takano M; Yasuhara M; Hattori H; Furusho K; Inui K
    Biol Pharm Bull; 1996 Mar; 19(3):444-8. PubMed ID: 8924916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical approximations of sensitivities of steady state predictions to errors in parameter estimation: II. Michaelis-Menten kinetics.
    Gonda I
    J Pharmacokinet Biopharm; 1984 Oct; 12(5):525-34. PubMed ID: 6520746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Population kinetic program for Michaelis-Menten elimination].
    Lü M; Zhou HW; Song JF
    Zhongguo Yao Li Xue Bao; 1990 Jan; 11(1):85-8. PubMed ID: 2403022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state pharmacokinetics of phenytoin from routinely collected patient data.
    Grasela TH; Sheiner LB; Rambeck B; Boenigk HE; Dunlop A; Mullen PW; Wadsworth J; Richens A; Ishizaki T; Chiba K
    Clin Pharmacokinet; 1983; 8(4):355-64. PubMed ID: 6617043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating inestimable standard errors in population pharmacokinetic studies: the bootstrap with Winsorization.
    Ette EI; Onyiah LC
    Eur J Drug Metab Pharmacokinet; 2002; 27(3):213-24. PubMed ID: 12365204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of new measures of nonlinearity to parameter estimation and simulations in individual pharmacokinetic analyses.
    Khinkis L; Crotzer M
    J Pharmacokinet Pharmacodyn; 2019 Feb; 46(1):43-52. PubMed ID: 30607795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiences in the application of NONMEM to pharmacokinetic data analysis.
    Flühler H; Huber H; Widmer E; Brechbühler S
    Drug Metab Rev; 1984; 15(1-2):317-39. PubMed ID: 6547665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the difficulties of fitting the double Michaelis-Menten equation to kinetic data.
    Bates JH; Bates DA; Mackillop W
    J Theor Biol; 1987 Mar; 125(2):237-41. PubMed ID: 3657211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulation for population analysis of Michaelis-Menten elimination kinetics.
    Hashimoto Y; Koue T; Otsuki Y; Yasuhara M; Hori R; Inui K
    J Pharmacokinet Biopharm; 1995 Apr; 23(2):205-16. PubMed ID: 8719237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A note on confidence intervals with extended least squares parameter estimates.
    Sheiner LB; Beal SL
    J Pharmacokinet Biopharm; 1987 Feb; 15(1):93-8. PubMed ID: 3625482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods.
    Sheiner LB; Beal SL
    J Pharm Sci; 1982 Dec; 71(12):1344-8. PubMed ID: 7153881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.